Boryung Corporation
003850 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003850005
- LEI:
- Country:
- South Korea
- Address:
- 서울 종로구 원남동 보령빌딩 66-21, 종로구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 3.8 MB | ||
| 2025-08-08 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 17.3 KB | ||
| 2025-07-31 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.1 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 138.9 KB | ||
| 2025-06-12 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 16.6 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-05 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 29.0 KB | ||
| 2025-06-02 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.2 KB | ||
| 2025-06-02 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 770.4 KB | ||
| 2025-05-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.4 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.2 MB | ||
| 2025-04-29 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.0 KB | ||
| 2025-04-25 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항
|
Korean | 16.8 KB | ||
| 2025-04-23 00:00 |
Prospectus
투자설명서
|
Korean | 4.0 MB |
Automate Your Workflow. Get a real-time feed of all Boryung Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Boryung Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Boryung Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
United States of America
ENTO
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
United States of America
TRDA
South Korea
183490
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Sweden
ENZY
Develops ingestible therapeutic devices for weight management and targeted drug delivery.
Israel
EPIT
Israel
EPIT
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Sweden
EQL
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America
ERAS
United States of America
ERAS
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
United States of America
ERNA
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France
ERYP
France
ERYP
Develops oral ACLY inhibitors to lower high LDL-C and cardiovascular risk.
United States of America
ESPR
United States of America
ESPR